(19)

(11)

EP 3 592 357 A1

(12)

(43) Date of publication: 15.01.2020 Bulletin 2020/03 (21) Application number: 17899634.4 (22) Date of filing: 21.09.2017

(51) International Patent Classification (IPC):  A61K 31/56(2006.01) A61K 31/575(2006.01) C07J 9/00(2006.01) A61K 31/133(2006.01) C07J 5/00(2006.01) C07J 31/00(2006.01) (86) International application number: PCT/US2017/052663 (87) International publication number: WO 2018/164715 (13.09.2018 Gazette 2018/37)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: MA MD (30) Priority: 07.03.2017 US 201762468259 P (71) Applicant: Intercept Pharmaceuticals, Inc. New York, NY 10001 (US)	(72) Inventors: MOSCHETTA, Antonio 70032 Bitonto Bari (IT) ASURMEDI, Jesús, Maria Bañales 20014 San Sebastián (ES) PIEROLA, Luis, Bujanda Fernandez De 20014 San Sebastián (ES) MONTIEL, Maria, Jesus Perugorria 20014 San Sebastián (ES) AZPARREN, Oihane, Erice 20014 San Sebastián (ES) (74) Representative: Cooley (UK) LLP  Dashwood 69 Old Broad Street London EC2M 1QS London EC2M 1QS (GB)